J.M.M. Gijtenbeek
J.M.M. Gijtenbeek has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
A.A.W.M. GabreëlS–Festen
From the Department of Neurology (Drs. Gabreëls–Festen, Lammens, and van Engelen), Neuromuscular Center Nijmegen; and the Departments of Neurology (Dr. Gijtenbeek), Pathology (Dr. Lammens), and Clinical Neurophysiology (Dr. Zwarts), University Medical Center, Nijmegen, the Netherlands
1 shared publicationB.G.M. van Engelen
From the Department of Neurology (Drs. Gabreëls–Festen, Lammens, and van Engelen), Neuromuscular Center Nijmegen; and the Departments of Neurology (Dr. Gijtenbeek), Pathology (Dr. Lammens), and Clinical Neurophysiology (Dr. Zwarts), University Medical Center, Nijmegen, the Netherlands
1 shared publicationM.J. Zwarts
From the Department of Neurology (Drs. Gabreëls–Festen, Lammens, and van Engelen), Neuromuscular Center Nijmegen; and the Departments of Neurology (Dr. Gijtenbeek), Pathology (Dr. Lammens), and Clinical Neurophysiology (Dr. Zwarts), University Medical Center, Nijmegen, the Netherlands
1 shared publication- Martin Lammens
Department of Pathology, Antwerp University Hospital (UZA), Edegem, Antwerp, Belgium
1 shared publication
Latest Publications
- 26 June 2001
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (12) , 1766-1768
Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2
The authors report a patient with neurofibromatosis type 2 (NF2) presenting with an axonal mononeuropathy multiplex. Sural nerve biopsy showed small scattered groups of Schwann cells transformed into irregular branching cells with abnormal cell—cell contacts. The authors hypothesize that defective Schwann cell function, due to inactivation of the NF2 gene product merlin, leads to changes in morphology, cell–cell contact, and growth, and finally to degeneration of axons.
- 26 June 2001
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (12) , 1766-1768
Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2
The authors report a patient with neurofibromatosis type 2 (NF2) presenting with an axonal mononeuropathy multiplex. Sural nerve biopsy showed small scattered groups of Schwann cells transformed into irregular branching cells with abnormal cell—cell contacts. The authors hypothesize that defective Schwann cell function, due to inactivation of the NF2 gene product merlin, leads to changes in morphology, cell–cell contact, and growth, and finally to degeneration of axons.